201. Novel CHD7 mutations contributing to the mutation spectrum in patients with CHARGE syndrome
- Author
-
Luhmer I, Kathrin Wessels, Brigitte Pabst, Jon Jonasson, Mine Arslan-Kirchner, Jörg Schmidtke, Manfred Stuhrmann, Susanne Morlot, Jörg T. Epplen, Gudrun Göhring, Stefanie Glaser, Dorothea Gadzicki, Madeleine Mälzer, Axel Bohring, Bettina Bohnhorst, and Anke Hein
- Subjects
Male ,Adolescent ,DNA Mutational Analysis ,Mutation, Missense ,Choanal atresia ,Biology ,medicine.disease_cause ,Frameshift mutation ,CHARGE syndrome ,Young Adult ,otorhinolaryngologic diseases ,Genetics ,medicine ,Missense mutation ,Humans ,Child ,Genetics (clinical) ,Mutation ,Coloboma ,Genome, Human ,DNA Helicases ,Infant, Newborn ,Infant ,General Medicine ,Nucleic acid amplification technique ,medicine.disease ,DNA-Binding Proteins ,Phenotype ,Child, Preschool ,Mutation testing ,Female ,CHARGE Syndrome ,Nucleic Acid Amplification Techniques - Abstract
CHARGE syndrome is an autosomal dominant inherited multiple malformation disorder typically characterized by coloboma, choanal atresia, hypoplastic semicircular canal, cranial nerve defects, cardiovascular malformations and ear abnormalities. Mutations in the chromodomain helicase DNA-binding protein 7 (CHD7) gene are the major cause of CHARGE syndrome. Mutation analysis was performed in 18 patients with firm or tentative clinical diagnosis of CHARGE syndrome. In this study eight mutations distributed across the gene were found. Five novel mutations - one missense (c.2936Tandgt;C), one nonsense (c.8093Candgt;A) and three frameshift mutations (c.804_805insAT, c.1757_1770del14, c.1793delA) - were identified. As far as familial data were available these mutations were found to have arisen de novo. Comparison of the clinical features of patients with the same mutation demonstrates that expression of the phenotype is highly variable. The mutation detection rate in this study was 44.4% in patients with a clinically established or suspected diagnosis of CHARGE syndrome.
- Published
- 2010